Sort
130,381 grants matching “hiv”
A universal MHC-E-restricted T cell vaccine for HIV
$931,503Jonah B. Sacha · Oregon Health & Science University · R01 · FY2018 · AI
An Interdisciplinary Approach to HIV and Other Infectious Diseases of Drug Users
$931,499Sherry Deren · National Development And Research Institutes, Inc. · P30 · FY2008 · DA
NONHUMAN PRIMATE CORE QUANT IRAL RNA LABORATORY FOR AIDS VACCINE R&D
$931,497Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2012 · AI
Behavioral Sciences Training in Drug Abuse Research
$931,485Gregory P Falkin · New York University · T32 · FY2018 · DA
A NOVEL, LOGICAL APPROACH TO HIV VACCINE DEVELOPMENT
$931,391University Of Wisconsin Madison · R01 · FY2003 · AI
Integrating HIV Prevention into Clinical Care for PLWHA in South Africa
$931,389Jeffrey D Fisher · University Of Connecticut Storrs · R01 · FY2011 · MH
Cost-effectiveness of preventing HIV complications
$931,350Kenneth Alan Freedberg · Massachusetts General Hospital · R37 · FY2012 · AI
PANDAA for universal, pan-lineage molecular detection of filoviruses to enable rapid epidemic response.
$931,246Iain James Macleod · Aldatu Biosciences, Inc. · R44 · FY2023 · AI
Platelet Exocytosis and Endocytosis in Thrombosis and Immunity
$931,163Sidney Waldo Whiteheart · University Of Kentucky · R35 · FY2025 · HL
Platelet Exocytosis and Endocytosis in Thrombosis and Immunity
$931,163Sidney Waldo Whiteheart · University Of Kentucky · R35 · FY2021 · HL
Platelet Exocytosis and Endocytosis in Thrombosis and Immunity
$931,163Sidney Waldo Whiteheart · University Of Kentucky · R35 · FY2023 · HL
Platelet Exocytosis and Endocytosis in Thrombosis and Immunity
$931,163Sidney Waldo Whiteheart · University Of Kentucky · R35 · FY2022 · HL
New anti-tubercular agents targeting intracellular bacteria
$931,143Tanya Parish · Seattle Children'S Hospital · R01 · FY2025 · AI
Mechanisms of CD4 downregulation by primate immunodeficiency viruses
$931,085Juan Bonifacino · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
Next generation hybrid nucleases for precise excision of latent HIV-1 provirus
$931,045Jeremy Luban · Univ Of Massachusetts Med Sch Worcester · R01 · FY2015 · AI
Identification and characterization of chromatin regulators of HIV-1 latency
$930,994Susana T Valente · Scripps Florida · R61 · FY2020 · AI
NYC Center of Excellence for Public Health Informatics
$930,959George M. Hripcsak · New York City Health/Mental Hygiene · P01 · FY2008 · CD
UNIVERSITY OF P.R., PEDIATRIC AIDS CLINICAL TRIALS UNIT
$930,940University Of Puerto Rico Med Sciences · U01 · FY2001 · AI
Virological Measurements of Cryptic Replication
$930,924Mario Stevenson · University Of Minnesota · P01 · FY2010 · AI
Optimizing HIV-malaria treatment in a shifting treatment and resistance landscape in Africa
$930,846Sunil Parikh · Yale University · R01 · FY2024 · HD
Bacterial and host determinants of progression, manifestations and consequences of TB
$930,827Reynaldo Dietze · Rutgers Biomedical And Health Sciences · U19 · FY2023 · AI
A National Test of a Culturally Tailored mHealth Integrated Smoking Cessation and Mental Health Intervention for Black Adults with HIV
$930,825Lorra Garey · University Of Houston · R01 · FY2024 · MD
Vulnerability to Drug Use & HIV: Advancing Prevention for Rural African Americans
$930,781Gene H Brody · University Of Georgia · P30 · FY2014 · DA
Retrovirus Assembly and Maturation
$930,640Alan Rein · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Embedding Pharmacogenotyping in an Integrated Health System for the Underserved
$930,586Todd C. Skaar · Indiana University Indianapolis · U01 · FY2017 · HG